All lanes : Anti-GLK antibody [3E3] (ab117856) at 1/500 dilutionLane 1 : HEK293T lysate transfected with pCMV6-ENTRY control cDNA for 48 hrs Lane 2 : HEK293T lysate transfected with pCMV6-ENTRY GLK cDNA for 48 hrs Lysates/proteins at 5 µg per lane.
Immunofluorescence image using ab117856 at a 1/100 dilution, staining COS7 transfected cells.
ab117856, at a 1/50 dilution, staining Human GLK in breast, using Immunohistochemistry, formalin/PFA-fixed paraffin embedded tissue.
ab117856, at a 1/50 dilution, staining Human GLK in breast adenocarcinoma, using Immunohistochemistry, formalin/PFA-fixed paraffin embedded tissue.
ab117856, at a 1/50 dilution, staining Human GLK in kidney, using Immunohistochemistry, formalin/PFA-fixed paraffin embedded tissue.
ab117856, at a 1/50 dilution, staining Human GLK in kidney carcinoma, using Immunohistochemistry, formalin/PFA-fixed paraffin embedded tissue.
ab117856, at a 1/50 dilution, staining Human GLK in lung , using Immunohistochemistry, formalin/PFA-fixed paraffin embedded tissue.
ab117856, at a 1/50 dilution, staining Human GLK in lung carcinoma, using Immunohistochemistry, formalin/PFA-fixed paraffin embedded tissue.
ab117856, at a 1/50 dilution, staining Human GLK in pancreas, using Immunohistochemistry, formalin/PFA-fixed paraffin embedded tissue.
ab117856, at a 1/50 dilution, staining Human GLK in thyroid carcinoma, using Immunohistochemistry, formalin/PFA-fixed paraffin embedded tissue.
ab117856, at a 1/50 dilution, staining Human GLK in prostrate carcinoma, using Immunohistochemistry, formalin/PFA-fixed paraffin embedded tissue.